Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: Results of a multicenter open-label prospective study

Philippe Mertz, J.F. Kleinmann, M. Lambert, Xavier Puéchal, Anthony Bonnin, Carine Boulon, Élisabeth Diot, É. Hachulla, Naoual Harid, Jean‐Robert Harlé, Helder Gil, Jean‐Emmanuel Kahn, Isabelle Koné‐Paut, Christian Lavigne, N. Magy‐Bertrand, Hélène Maillard, Thierry Martin, F. Maurier, Vincent Poindron, N. Schleinitz, Jean Sibilia, Laurent Arnaud